The Academy of Oncology Nurse Navigators white paper, "Assessing the Creative Application and Usefulness of NSider: A Tactical Tool for the Oncology Nurse Navigator" was published in the journal, The Oncology Nurse-APN/NP.

Breast cancer gene may also be linked to high-risk uterine cancerThe Associated Press via Fox NewsWomen with a faulty breast cancer gene might face a greater chance of rare but deadly uterine tumors despite having their ovaries removed to lower their main cancer risks, doctors are reporting. A study of nearly 300 women with bad BRCA1 genes found four cases of aggressive uterine cancers years after they had preventive surgery to remove their ovaries.

How your genes help you become a good parentTIMEOr a bad one, for that matter. A new study suggests both genetic and environmental factors determine how a parent is likely to raise a child, both positively and negatively. Scared expectant parents are always told that knowing how to take care of their offspring just comes naturally. Turns out a new study by Michigan State University psychologists backs up that theory with cold, hard facts.

Want to get published?MultiBriefsIn an effort to enhance the overall content of Genomics Biotech and Emerging Medical Technologies Institute eBrief, we'd like to include peer-written articles in future editions. As a member, your knowledge of the industry lends itself to unprecedented expertise. And we're hoping you'll share this expertise with your peers through well-written commentary. Because of the digital format, there's no word or graphical limit and our group of talented editors can help with final edits. If you're interested in participating, please contact Ronnie Richard to discuss logistics.

Scientists tweak genes to give bacteria electrical superpowersWiredThe sticky bacterial mats called biofilms — the stuff that coats your teeth with plaque and help give Yellowstone's hot springs their crazy colors — are pretty impressive. Cells in the conglomerate can talk to one another and coordinate switching genes on and off, and the biofilm as a whole can quickly react to shifting environmental conditions.

Breast cancer genes and patient protection in an era of personalized medicineThe Huffington PostGenetic testing is often heralded as a cornerstone in an imminent and exciting new age of personalized medicine, in which our healthcare is customized based on our individual genetic profiles. But let's not get carried away by the fantasy and promise; progress has lagged while persistent medical, ethical and scientific issues associated with genetic testing abound.

Building the Google of blood, 1 tube at a timeThe New YorkerThe first shipment arrives at 4 am. The boxes are opened by laser — in case a hand should slip and plunge a knife into the tightly packed dry ice. Here, suspended in the thousands of test tubes that arrive each day, is an endless stream of blood. If one of the tubes is yours, you have probably run out of options &mdahs; except for the last gamble of a clinical trial.

Scientists develop unique cells to repair patient's defective and diseased bladderNews-Medical.netFor the first time, scientists have succeeded in coaxing laboratory cultures of human stem cells to develop into the specialized, unique cells needed to repair a patient's defective or diseased bladder. The breakthrough, developed at the UC Davis Institute for Regenerative Cures and published in the scientific journal Stem Cells Translational Medicine, is significant because it provides a pathway to regenerate replacement bladder tissue for patients whose bladders are too small or do not function properly, such as children with spina bifida and adults with spinal cord injuries or bladder cancer.

Replacing insulin through stem cell-derived pancreatic cells under the skinMedical XpressSanford-Burnham Medical Research Institute and UC San Diego School of Medicine scientists have shown that by encapsulating immature pancreatic cells derived from human embryonic stem cells, and implanting them under the skin in animal models of diabetes, sufficient insulin is produced to maintain glucose levels without unwanted potential trade-offs of the technology.

3-D printing is revolutionizing surgeryCrain's Chicago Business via Modern HealthcareReaching into a beat-up, red-and-white cooler lined with a white terry-cloth towel, Dr. Matthew Bramlet pulls out a replica of an infant's heart. The size of a small pear and chalky to the touch, the model was made in a 3-D printer. Last spring, Dr. Bramlet, 38, a pediatric cardiologist at Children's Hospital of Illinois in Peoria, commissioned it from the hospital's new innovation lab while planning surgery for a girl with a congenital heart defect.

Can aspirin prevent heart attacks? This device may know the answerCNETToday, if researchers want to know how well a drug like aspirin works at preventing heart attacks, the traditional approach is to test that drug on as many people as possible and try to consider a variety of contributing factors, such as age, gender, race and heart health. But a prototype microfluidic device being tested at Georgia Tech could enable researchers to instead run a sample of a patient's blood through artificial arteries and, instead of estimating how well the drug should work in most patients, determine exactly how well it works in that very patient's body.

Scientists home in on the real 'fat gene'Los Angeles TimesIf you're a student of fat — and who isn't these days? — you know that the FTO gene is the gene thought to be most responsible for some people's inherited propensity to become obese.

Affordable Care Act may actually lead to fewer clinical visitsBy Pamela Lewis Dolan With an estimated 30 million people expected to gain insurance coverage through the Affordable Care Act, there has been much speculation about where those patients will go for care. Many physician offices are already filled to capacity, and a looming shortage of primary care physicians has been well-documented. While it may seem counterintuitive, a number of providers fear the ACA will actually lead to fewer visits in some cases, despite the growing patient population.

Survey: Health insurance basics stump many Obamacare shoppersLos Angeles TimesAmid the final frenzy for Obamacare enrollment, a new survey shows that many consumers may be ill-equipped to shop for health insurance. A study published in the Proceedings of the National Academy of Sciences found that 42 percent of people surveyed could not describe a deductible and 39 percent didn't understand the relationship between a premium and deductible.

For some who are married but filing taxes separately, another HealthCare.gov hurdleThe Associated Press via The Washington PostIn May 2012, when the Internal Revenue Service proposed its rules for Americans to get government subsidies for health insurance, officials acknowledged that a legal quirk needed to be fixed: The Affordable Care Act was written in a way that inadvertently denied such help to some people who live apart from spouses who abuse them, are in prison or are on the cusp of a divorce.

FDA reviewers recommend against approval for Novartis heart failure drugForbesAhead of an important advisory panel FDA reviewers have recommended against approval of a novel drug for acute heart failure from Novartis. The once highly-promising drug, which received a "breakthrough therapy" designation from the FDA last year, was turned down for approval in Europe earlier this year.

FDA approves Celgene drug for psoriatic arthritisReuters via Yahoo NewsU.S. health regulators approved a Celgene Corp drug to treat psoriatic arthritis, a type of arthritis associated with the skin disease psoriasis that causes joint pain, stiffness and swelling.
The drug, known chemically as apremilast, will be sold under the brand name Otezla. It is also being studied by the U.S. biotechnology company as a treatment for psoriasis and ankylosing spondylitis.

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!